Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
GLP-1 drugs are widely used in this population, yet robust clinical guidance is still evolving
PMID: Summary Keywords Crohns disease, GLP, GLP-1, GLP-2 receptor agonist, IBD - inflammatory bowel disease, ulcerative colitis Citation Lee JJ, Bajgain P and Lightner AL (2026) GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity
Not eligible : Once status is Queued for Shipment , change-of-mind cancellations are not possible
Food and Drug Administration (FDA) approved Foundayo(TM) (orforglipron) for adults with obesity or who are overweight with weight-related medical problems
US$ 29.16
US$ 20.76
US$ 20.05
US$ 20.09
US$ 26.04
